World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
107
Citations
37439
World Ranking
549
National Ranking
328

Medicine

D-Index
107
Citations
37563
World Ranking
6319
National Ranking
3369

Gilla Kaplan publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Gilla Kaplan sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 304 publications — 65th percentile

65% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Gilla Kaplan D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Gilla Kaplan sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 107 D-Index — 89th percentile

89% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Gilla Kaplan is affiliated with the Bill & Melinda Gates Foundation in the United States. Their research primarily focuses on the field of medicine, with specific attention to epidemiology, infectious diseases, surgery, neurology, and immunology. The scientist's work spans multiple topics including tuberculosis research and epidemiology, Mycobacterium research and diagnosis, infectious diseases and tuberculosis, Pneumocystis jirovecii pneumonia detection and treatment, inhalation and respiratory drug delivery, multiple myeloma research and treatments, and peripheral neuropathies and disorders.

Kaplan has contributed to a number of research papers published in various scientific venues. Some recent publications include:

  • "Capture and visualization of live Mycobacterium tuberculosis bacilli from tuberculosis patient bioaerosols" (2021), published in PLoS Pathogens
  • "Thalidomide and Phosphodiesterase 4 Inhibitors as Host Directed Therapeutics for Tuberculous Meningitis: Insights From the Rabbit Model" (2020), published in Frontiers in Cellular and Infection Microbiology
  • "Inoculum size and traits of the infecting clinical strain define the protection level against Mycobacterium tuberculosis infection in a rabbit model" (2020), published in European Journal of Immunology
  • "Aggregation state of Mycobacterium tuberculosis impacts host immunity and augments pulmonary disease pathology" (2021), published in Communications Biology
  • "Aggregated Mycobacterium tuberculosis Enhances the Inflammatory Response" (2021), published in Frontiers in Microbiology

These papers highlight a detailed focus on tuberculosis and host-pathogen interactions, often utilizing animal models to study disease pathology and immune response mechanisms.

The scientist frequently publishes in venues such as bioRxiv (Cold Spring Harbor Laboratory), PLoS Pathogens, Communications Biology, Frontiers in Cellular and Infection Microbiology, and the European Journal of Immunology.

Collaborations are an integral part of Kaplan's work, with frequent coauthors including:

  • Afsal Kolloli
  • Selvakumar Subbian
  • Pooja Singh
  • Ranjeet Kumar
  • Alex Sigal

These coauthors have contributed to multiple publications together, indicating active research partnerships especially in infectious disease and immunology-related studies.

Best Publications

  • Thalidomide selectively inhibits tumor necrosis factor alpha production by stimulated human monocytes.

    E P Sampaio;E N Sarno;R Galilly;Z A Cohn

  • Thalidomide exerts its inhibitory action on tumor necrosis factor alpha by enhancing mRNA degradation.

    A L Moreira;E P Sampaio;A Zmuidzinas;P Frindt

  • A glycolipid of hypervirulent tuberculosis strains that inhibits the innate immune response

    Michael B. Reed;Pilar Domenech;Claudia Manca;Hua Su

  • Differential cytokine modulation and T cell activation by two distinct classes of thalidomide analogues that are potent inhibitors of TNF-alpha.

    Laura G. Corral;Patrick A. J. Haslett;George W. Muller;Roger Chen

  • Virulence of a Mycobacterium tuberculosis clinical isolate in mice is determined by failure to induce Th1 type immunity and is associated with induction of IFN-α/β

    Claudia Manca;Liana Tsenova;Amy Bergtold;Sherry Freeman

  • Toll-like receptor–induced arginase 1 in macrophages thwarts effective immunity against intracellular pathogens

    Karim C El Kasmi;Joseph E Qualls;John T Pesce;Amber M Smith

  • Thalidomide Costimulates Primary Human T Lymphocytes, Preferentially Inducing Proliferation, Cytokine Production, and Cytotoxic Responses in the CD8+ Subset

    Patrick A.J. Haslett;Laura G. Corral;Matthew Albert;Gilla Kaplan

  • Identification of a novel cell type in peripheral lymphoid organs of mice. V. Purification of spleen dendritic cells, new surface markers, and maintenance in vitro.

    Ralph M. Steinman;Gilla Kaplan;Margaret D. Witmer;Zanvil A. Cohn

  • Apoptosis, but not necrosis, of infected monocytes is coupled with killing of intracellular bacillus Calmette-Guérin

    A Molloy;P Laochumroonvorapong;G Kaplan

  • Metformin as adjunct antituberculosis therapy

    Amit Singhal;Liu Jie;Pavanish Kumar;Gan Suay Hong

  • Caseation of human tuberculosis granulomas correlates with elevated host lipid metabolism

    Mi-Jeong Kim;Helen C. Wainwright;Michael Locketz;Linda-Gail Bekker

  • Human dendritic cells. Enrichment and characterization from peripheral blood.

    WC Van Voorhis;LS Hair;RM Steinman;G Kaplan

  • Specific T Cell Frequency and Cytokine Expression Profile Do Not Correlate with Protection against Tuberculosis after Bacillus Calmette-Guérin Vaccination of Newborns

    Benjamin M. N. Kagina;Brian Abel;Thomas J. Scriba;Elizabeth J. Hughes

  • The Influence of Thalidomide on the Clinical and Immunologic Manifestation of Erythema Nodosum Leprosum

    Elizabeth P. Sampaio;Gilla Kaplan;Alice Miranda;Jose A. C. Nery

  • Amino-substituted thalidomide analogs: Potent inhibitors of TNF-α production

    George W. Muller;Roger Chen;Shaei-Yun Huang;Laura G. Corral

  • The role of RelMtb-mediated adaptation to stationary phase in long-term persistence of Mycobacterium tuberculosis in mice.

    John L. Dahl;Carl N. Kraus;Helena I. M. Boshoff;Bernard Doan

  • Mycobacterium tuberculosis Growth at the Cavity Surface: a Microenvironment with Failed Immunity

    Gilla Kaplan;Frank A. Post;Andre L. Moreira;Helen Wainwright

  • Mycobacterium tuberculosis CDC1551 induces a more vigorous host response in vivo and in vitro, but is not more virulent than other clinical isolates

    Claudia Manca;Liana Tsenova;Clifton E. Barry;Amy Bergtold

  • Functional capacity of Mycobacterium tuberculosis-specific T cell responses in humans is associated with mycobacterial load

    Cheryl L. Day;Cheryl L. Day;Deborah A. Abrahams;Lesedi Lerumo;Esme Janse van Rensburg

  • Local and Systemic Effects of Intradermal Recombinant Interferon-γ in Patients with Lepromatous Leprosy

    Carl F. Nathan;Gilla Kaplan;William R. Levis;Ali Nusrat

  • Thalidomide Exerts Its Inhibitory Action on Tumor Necrosis Factor oe by Enhancing mRNA Degradation By Andre L. Moreira,* Elizabeth P. Sampaio,*S Antonina Zmuidzinas,*

    Paula Frindt;Kendall A. Smith;Gilla Kaplan

Frequent Co-Authors

Zanvil A. Cohn
Zanvil A. Cohn Rockefeller University
Willem A. Hanekom
Willem A. Hanekom University College London
Linda-Gail Bekker
Linda-Gail Bekker University of Cape Town
Clifton E. Barry
Clifton E. Barry National Institute of Allergy and Infectious Diseases
Barry N. Kreiswirth
Barry N. Kreiswirth Center for Discovery and Innovation
Barun Mathema
Barun Mathema Columbia University
Euzenir Nunes Sarno
Euzenir Nunes Sarno Oswaldo Cruz Foundation
Frank A. Post
Frank A. Post King's College London
Elizabeth P. Sampaio
Elizabeth P. Sampaio National Institutes of Health
Thomas J. Scriba
Thomas J. Scriba University of Cape Town

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in expanding their expertise beyond Immunology, pursuing advanced nursing degrees online is a popular pathway. Many professionals consider accelerated programs to fast-track their careers, such as the accelerated FNP programs. These are designed for nurses aiming to become Family Nurse Practitioners in a shorter timeframe.

Transitioning from a Family Nurse Practitioner to an Acute Care NP also offers a specialized route with additional certification. This transition can help broaden clinical skills and open doors to critical care settings, as detailed in the guide on acute care certification for FNP.

For individuals without a nursing background, 12-month programs like the 12-month accelerated nursing programs online for non nurses provide a fast entry into the nursing field. These intensive programs prepare students for foundational nursing roles with flexibility.

Lastly, understanding the financial outlook is crucial. The variation in earnings, such as the DNP salary across different states, can influence career decisions and geographic mobility within healthcare professions.

Best Scientists Citing Gilla Kaplan

Trending Scientists

Recently Published Articles